Sulfamoyl sulfonate prodrugs

Details for Australian Patent Application No. 2006319380 (hide)

Owner Bayer Schering Pharma Aktiengesellschaft

Inventors Ganzer, Ursula; Nubbemeyer, Reinhard; Wyrwa, Ralf

Agent Davies Collison Cave

Pub. Number AU-A-2006319380

PCT Pub. Number WO2007/062874

Priority 10 2005 057 408.4 30.11.05 DE

Filing date 27 November 2006

Wipo publication date 7 June 2007

International Classifications

A61K 31/565 (2006.01) - not substituted in position 17 beta by a carbon atom, e.g. oestrane, oestradiol

A61P 5/26 (2006.01) Drugs for disorders of the endocrine system

A61P 5/30 (2006.01) Drugs for disorders of the endocrine system

C07J 41/00 (2006.01) Normal steroids, i.e. cyclopenta[a]hydrophenanthrenes, containing nitrogen

Event Publications

24 July 2008 PCT application entered the National Phase

  PCT publication WO2007/062874 Priority application(s): WO2007/062874

4 November 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006319381-Heteroaromatic sulfonamide prodrugs

2006319370-Polymer composition having a high refractive index